911 related articles for article (PubMed ID: 34503576)
1. Synaptic tau: A pathological or physiological phenomenon?
Robbins M; Clayton E; Kaminski Schierle GS
Acta Neuropathol Commun; 2021 Sep; 9(1):149. PubMed ID: 34503576
[TBL] [Abstract][Full Text] [Related]
2. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
3. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration and plasticity.
Arendt T
Int J Dev Neurosci; 2004 Nov; 22(7):507-14. PubMed ID: 15465280
[TBL] [Abstract][Full Text] [Related]
5. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
6. Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives.
Lista S; Santos-Lozano A; Emanuele E; Mercuri NB; Gabelle A; López-Ortiz S; Martín-Hernández J; Maisto N; Imbimbo C; Caraci F; Imbimbo BP; Zetterberg H; Nisticò R
Mol Psychiatry; 2024 Mar; 29(3):847-857. PubMed ID: 38228892
[TBL] [Abstract][Full Text] [Related]
7. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
Hochgräfe K; Sydow A; Mandelkow EM
FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
[TBL] [Abstract][Full Text] [Related]
8. Synaptic Plasticity, Dementia and Alzheimer Disease.
Skaper SD; Facci L; Zusso M; Giusti P
CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
[TBL] [Abstract][Full Text] [Related]
9. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
10. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
11. Dendritic Tau in Alzheimer's Disease.
Ittner A; Ittner LM
Neuron; 2018 Jul; 99(1):13-27. PubMed ID: 30001506
[TBL] [Abstract][Full Text] [Related]
12. Minimalistic in vitro systems for investigating tau pathology.
Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
[TBL] [Abstract][Full Text] [Related]
13. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.
Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G
J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603
[TBL] [Abstract][Full Text] [Related]
14. The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
Spires-Jones TL; Hyman BT
Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936
[TBL] [Abstract][Full Text] [Related]
15. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
Terwel D; Dewachter I; Van Leuven F
Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
[TBL] [Abstract][Full Text] [Related]
16. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
17. [Present and future of the tau dementia therapy].
Takashima A
Rinsho Shinkeigaku; 2013; 53(11):1040-2. PubMed ID: 24291873
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
19. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.
Mandelkow EM; Stamer K; Vogel R; Thies E; Mandelkow E
Neurobiol Aging; 2003 Dec; 24(8):1079-85. PubMed ID: 14643379
[TBL] [Abstract][Full Text] [Related]
20. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]